EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase

Kazuki Nishida iD, Basile Chrétien iD, Hiroshi Morioka iD, Daigo Tamakoshi iD, Keita Hiraga iD, Tomoyuki Nakamura iD, Shigeyuki Matsui iD, Masahisa Katsuno iD, Yoshitaka Hara iD

Clinical and Translational Science · 2026-04 · 19 (4)

DOI: 10.1111/cts.70534 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical and Translational Science, online erschienen am 10.04.2026. Verfasst von Kazuki Nishida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Clindamycin, Cefazolin, Anti-Bacterial Agents. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, Uppsala Monitoring Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clindamycin is a common β‐lactam substitute for surgical prophylaxis. Whether peri‐operative disturbances in consciousness are disproportionately reported with clindamycin in global pharmacovigilance data remains unclear. Using WHO VigiBase (up to January 27, 2025), we performed a de‐duplicated case/non‐case disproportionality analysis of Individual Case Safety Reports (ICSRs) co‐reporting ≥ 1 anesthetic or sedative. Cases were defined by the MedDRA HLT “Disturbances in consciousness NEC.” We estimated RORs and aRORs for clindamycin versus cefazolin and other peri‐operative comparators (metronidazole, vancomycin, ampicillin), adjusting for age group, sex, and co‐reported medications. K‐modes clustering characterized co‐reporting patterns among clindamycin reports. Sensitivity analyses excluded sepsis‐related terms/vasopressors and applied a narrower outcome definition excluding syncope/presyncope. Of 3623 clindamycin ICSRs, 159 (4.4%) included a consciousness‐disturbance term. Versus cefazolin, clindamycin generated a disproportionality signal (ROR 2.59, 95% CI 2.07–3.24; aROR 2.23, 95% CI 1.70–2.91), with similar estimates after excluding sepsis/vasopressors (aROR 2.21, 95% CI 1.64–2.98) and syncope/presyncope (aROR 2.11, 95% CI 1.60–2.79). Clustering suggested co‐reporting patterns consistent with lidocaine‐enriched older‐age reports, sedative/anesthetic‐enriched younger‐age reports, and opioid‐enriched reports with high‐acuity markers. In VigiBase, disproportionality analyses identified a reporting signal for disturbances in consciousness with clindamycin relative to cefazolin in surgical settings. Because spontaneous reports lack exposure denominators and are susceptible to residual confounding, these findings are hypothesis‐generating and do not estimate incidence or comparative risk. Evaluation in data sources with denominators and prospective clinical characterization is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClindamycinCefazolinAnti-Bacterial AgentsHumansPharmacovigilanceFemaleMaleMiddle AgedAdultAgedAntibiotic ProphylaxisAdolescentAdverse Drug Reaction Reporting SystemsYoung Adult

Stichwörter der Autor:innen

cefazolinclindamycinconsciousness disorderspharmacovigilancesurgical prophylaxis

Substanzen

ClindamycinCefazolinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biostatistics, School of Public Health, Kyoto University, Kyoto, Japan.
  • Department of Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • International Medical Education Department, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Infectious Diseases, Nagoya University Hospital, Nagoya, Aichi, Japan.
  • Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

ORCID-Profile: Kazuki Nishida, Basile Chrétien, Hiroshi Morioka, Daigo Tamakoshi, Keita Hiraga, Tomoyuki Nakamura, Shigeyuki Matsui, Masahisa Katsuno, Yoshitaka Hara

Förderung

  • World Health Organization
  • Uppsala Monitoring Centre

Zitieren

APA

Nishida, K., Chrétien, B., Morioka, H., Tamakoshi, D., Hiraga, K., Nakamura, T., Matsui, S., Katsuno, M., & Hara, Y. (2026). Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase. Clinical and Translational Science, 19(4). https://doi.org/10.1111/cts.70534

Vancouver

Nishida K, Chrétien B, Morioka H, Tamakoshi D, Hiraga K, Nakamura T, et al. Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase. Clinical and Translational Science. 2026;19(4). doi:10.1111/cts.70534

BibTeX
@article{Nishida2026,
  author = {Nishida, Kazuki and Chrétien, Basile and Morioka, Hiroshi and Tamakoshi, Daigo and Hiraga, Keita and Nakamura, Tomoyuki and Matsui, Shigeyuki and Katsuno, Masahisa and Hara, Yoshitaka},
  title = {Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {4},
  doi = {10.1111/cts.70534}
}
Kostenlos starten →